reference/3211206

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3211206

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Comparative Study\|Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	1175
issn	1068-9265 1534-4681
issueIdentifier	4
pageRange	1168-1175
publicationName	Annals of Surgical Oncology
startingPage	1168
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e9d595d045bba35b388e4914de298b07 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ab80a732b5df33e85751c0a758afb577
bibliographicCitation	Roland CL, Yang AD, Katz MHG, Chatterjee D, Wang H, Lin H, Vauthey JN, Pisters PW, Varadhachary GR, Wolff RA, Crane CH, Lee JE, Fleming JB. Neoadjuvant Therapy is Associated with a Reduced Lymph Node Ratio in Patients with Potentially Resectable Pancreatic Cancer. Annals of Surgical Oncology. 2014 Oct 29;22(4):1168–75. doi: 10.1245/s10434-014-4192-6.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ce2ba53957a89ca093635f5d9c14b9b1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d3ce0d253201dd29392989579b26ae23 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5774b955c53b0be992b2d256614d6248 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_faa8178bed808d79361e703026631fe5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cae39594b9d331dd97243f9da7e385ec http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aeaf969a95fafb04133f42d14c4f0189 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e5895dee3222f15dfcd8d981d6ede06d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d1b9837688eb1908554fab78eb11b097 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f57303bb1d6c4cd61ea50d397bedb3a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97399fa7072bd0a787d70e9cc1a196ad http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf514539ebb0283a7a28aaf1eca3f9b3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0b21e6f35fdd64986a15051736a74952 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7eedc5a4258e084f0fd7a8950c110140
date	2014-10-29^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/25352267 https://doi.org/10.1245/s10434-014-4192-6 https://pubmed.ncbi.nlm.nih.gov/PMC5131370
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8578 https://portal.issn.org/resource/ISSN/1068-9265 https://portal.issn.org/resource/ISSN/1534-4681
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Neoadjuvant Therapy is Associated with a Reduced Lymph Node Ratio in Patients with Potentially Resectable Pancreatic Cancer
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000230Q000628 http://id.nlm.nih.gov/mesh/D009364Q000628 http://id.nlm.nih.gov/mesh/D020360 http://id.nlm.nih.gov/mesh/D021441Q000628 http://id.nlm.nih.gov/mesh/D010190Q000628 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D008198Q000473
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D008207 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000230Q000556 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D009364Q000473 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D009361 http://id.nlm.nih.gov/mesh/D010180 http://id.nlm.nih.gov/mesh/D009364Q000401 http://id.nlm.nih.gov/mesh/D010190Q000401 http://id.nlm.nih.gov/mesh/D021441Q000401 http://id.nlm.nih.gov/mesh/D021441Q000556 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D000230Q000401 http://id.nlm.nih.gov/mesh/D003131 http://id.nlm.nih.gov/mesh/D010190Q000473 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D060787 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8382 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8766

Showing number of triples: 1 to 71 of 71.